论文部分内容阅读
目的:探讨小儿支气管哮喘的诱发因素及治疗方法。方法:对我院2009年12月—2010年6月收治的32例支气管哮喘患儿,总结其诱发因素,随机分为观察组和对照组,对照组采用吸氧、镇静、抗感染等常规治疗,观察组在对照组的基础上加用普米克和博利康尼2种药物超声雾化吸入,4mg/d。结果:该组患儿主要诱发因素为上呼吸道感染,占90.6%(29/32)。治疗后观察组患儿显效11例,好转4例,总有效率为93.8%(15/16),相比对照组81.3%(13/16)有统计学差异(P<0.05)。结论:普米克和博利康尼2种药物超声雾化吸入治疗小儿哮喘临床效果较好,可明显缓解症状。
Objective: To investigate the predisposing factors and treatment of bronchial asthma in children. Methods: Thirty-two children with bronchial asthma admitted from December 2009 to June 2010 in our hospital were enrolled in this study. The inducing factors were randomly divided into observation group and control group. The control group was given conventional therapy such as oxygen inhalation, sedation and anti-infection The observation group was given ultrasonic inhalation of 2 kinds of drugs, Pulmicort and Boriesonic, 4 mg / d on the basis of the control group. Results: The main predisposing factor in this group was upper respiratory tract infection, accounting for 90.6% (29/32). After treatment, the observation group had 11 cases markedly improved and 4 cases improved. The total effective rate was 93.8% (15/16), which was significantly higher than that of the control group (81.3%, 13/16) (P <0.05). Conclusion: Pulmicort and Boli Kang Ni two kinds of drugs ultrasonic atomization inhalation treatment of pediatric asthma clinical effect is good, can significantly relieve symptoms.